Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Phenotypic analysis of monocytes and CD4+ T cells in hepatitis E patients with or without pregnancy.

Arya RP, Arankalle VA.

Hum Immunol. 2019 Oct;80(10):855-862. doi: 10.1016/j.humimm.2019.06.011. Epub 2019 Jul 5.

PMID:
31285077
2.

Seroepidemiology of respiratory syncytial virus in western India with special reference to appropriate age for infant vaccination.

Arankalle VA, Kulkarni R, Malshe N, Palkar S, Lalwani S, Mishra AC.

J Med Virol. 2019 Aug;91(8):1566-1570. doi: 10.1002/jmv.25489. Epub 2019 May 6.

PMID:
31012488
3.

Detection of human parvovirus 4 DNA in the patients with acute encephalitis syndrome during seasonal outbreaks of the disease in Gorakhpur, India.

Arankalle VA, Srivastava N, Kushwaha KP, Sen A, Ramdasi AY, Patel PA, Kuthe S, Haldipur B, Sakpal GN, Lole KS, Ingle NB.

Emerg Microbes Infect. 2019;8(1):130-138. doi: 10.1080/22221751.2018.1563455.

4.

Risk of transfusion-associated dengue: screening of blood donors from Pune, western India.

Kulkarni R, Tiraki D, Wani D, Mishra AC, Arankalle VA.

Transfusion. 2019 Feb;59(2):458-462. doi: 10.1111/trf.15007. Epub 2018 Nov 10.

PMID:
30727040
5.

Association of Toll-like receptor 4 polymorphism with hepatitis E virus-infected Indian patients.

Arya RP, Mishra N, Biswas K, Arankalle VA.

J Viral Hepat. 2018 Dec;25(12):1617-1623. doi: 10.1111/jvh.12980. Epub 2018 Sep 19.

PMID:
30112862
6.

Stratified sero-prevalence revealed overall high disease burden of dengue but suboptimal immunity in younger age groups in Pune, India.

Mishra AC, Arankalle VA, Gadhave SA, Mahadik PH, Shrivastava S, Bhutkar M, Vaidya VM.

PLoS Negl Trop Dis. 2018 Aug 6;12(8):e0006657. doi: 10.1371/journal.pntd.0006657. eCollection 2018 Aug.

7.

Co-circulation of all the four dengue virus serotypes and detection of a novel clade of DENV-4 (genotype I) virus in Pune, India during 2016 season.

Shrivastava S, Tiraki D, Diwan A, Lalwani SK, Modak M, Mishra AC, Arankalle VA.

PLoS One. 2018 Feb 22;13(2):e0192672. doi: 10.1371/journal.pone.0192672. eCollection 2018.

8.

Inter-Clade Protection Offered by Mw-Adjuvanted Recombinant HA, NP Proteins, and M2e Peptide Combination Vaccine in Mice Correlates with Cellular Immune Response.

Ingle NB, Virkar RG, Arankalle VA.

Front Immunol. 2017 Jan 9;7:674. doi: 10.3389/fimmu.2016.00674. eCollection 2016.

9.

Specific memory B cell response and participation of CD4+ central and effector memory T cells in mice immunized with liposome encapsulated recombinant NE protein based Hepatitis E vaccine candidate.

Kulkarni SP, Thanapati S, Arankalle VA, Tripathy AS.

Vaccine. 2016 Nov 21;34(48):5895-5902. doi: 10.1016/j.vaccine.2016.10.046. Epub 2016 Oct 27.

PMID:
27997340
10.
11.

Differential Immune Responses in Mice Immunized with Recombinant Neutralizing Epitope Protein of Hepatitis E Virus Formulated with Liposome and Alum Adjuvants.

Joshi SS, Arankalle VA.

Viral Immunol. 2016 Jul-Aug;29(6):350-60. doi: 10.1089/vim.2016.0024. Epub 2016 Jun 10.

PMID:
27285290
12.

Hepatitis E virus (HEV)-1 harbouring HEV-4 non-structural protein (ORF1) replicates in transfected porcine kidney cells.

Chatterjee SN, Devhare PB, Pingle SY, Paingankar MS, Arankalle VA, Lole KS.

J Gen Virol. 2016 Aug;97(8):1829-1840. doi: 10.1099/jgv.0.000478. Epub 2016 Apr 12.

PMID:
27072797
13.

Genomic characterization of Salmonella bacteriophages isolated from India.

Karpe YA, Kanade GD, Pingale KD, Arankalle VA, Banerjee K.

Virus Genes. 2016 Feb;52(1):117-26. doi: 10.1007/s11262-015-1269-7. Epub 2016 Jan 12.

PMID:
26757942
14.

Identification and characterization of cellular proteins interacting with Hepatitis E virus untranslated regions.

Paingankar MS, Arankalle VA.

Virus Res. 2015 Oct 2;208:98-109. doi: 10.1016/j.virusres.2015.06.006. Epub 2015 Jun 15.

PMID:
26087402
15.
16.

Envelope specific T cell responses & cytokine profiles in chikungunya patients hospitalized with different clinical presentations.

Tripathy AS, Tandale BV, Balaji SS, Hundekar SL, Ramdasi AY, Arankalle VA.

Indian J Med Res. 2015 Feb;141(2):205-12.

17.

Toll like receptors in self-recovering hepatitis E patients with or without pregnancy.

Arya RP, Arankalle VA.

Hum Immunol. 2014 Dec;75(12):1147-54. doi: 10.1016/j.humimm.2014.10.011. Epub 2014 Oct 17.

PMID:
25454620
18.

Circulation of genotype-I hepatitis B virus in the primitive tribes of Arunachal Pradesh in early sixties and molecular evolution of genotype-I.

Haldipur BP, Walimbe AM, Arankalle VA.

Infect Genet Evol. 2014 Oct;27:366-74. doi: 10.1016/j.meegid.2014.07.036. Epub 2014 Aug 19.

PMID:
25149225
19.
20.

Identification of chikungunya virus interacting proteins in mammalian cells.

Paingankar MS, Arankalle VA.

J Biosci. 2014 Jun;39(3):389-99.

21.

Suppressive activity and altered conventional phenotype markers/mediators of regulatory T cells in patients with self-limiting hepatitis E.

Rathod SB, Das R, Thanapati S, Arankalle VA, Tripathy AS.

J Viral Hepat. 2014 Feb;21(2):141-51. doi: 10.1111/jvh.12125. Epub 2013 Jul 1.

PMID:
24383927
22.

Administration of E2 and NS1 siRNAs inhibit chikungunya virus replication in vitro and protects mice infected with the virus.

Parashar D, Paingankar MS, Kumar S, Gokhale MD, Sudeep AB, Shinde SB, Arankalle VA.

PLoS Negl Trop Dis. 2013 Sep 5;7(9):e2405. doi: 10.1371/journal.pntd.0002405. eCollection 2013.

23.

Analysis of antiviral response in human epithelial cells infected with hepatitis E virus.

Devhare PB, Chatterjee SN, Arankalle VA, Lole KS.

PLoS One. 2013 May 9;8(5):e63793. doi: 10.1371/journal.pone.0063793. Print 2013.

24.

Serum immunoglobulin G subclass responses in different phases of hepatitis E virus infection.

Deshmukh TM, Shah RR, Gurav YK, Arankalle VA.

J Med Virol. 2013 May;85(5):828-32. doi: 10.1002/jmv.23537.

PMID:
23508908
25.

Altered expressions of peripheral CD11c, CD80, CD83 markers and associations of HLA class II allele and haplotypes in self-limiting Hepatitis E infection.

Das R, Rathod SB, Alagarasu K, Arankalle VA, Tripathy AS.

Hum Immunol. 2013 Mar;74(3):277-85. doi: 10.1016/j.humimm.2012.12.010. Epub 2012 Dec 13.

PMID:
23246582
26.

Hepatitis E virus from India exhibits significant amino acid mutations in fulminant hepatic failure patients.

Mishra N, Walimbe AM, Arankalle VA.

Virus Genes. 2013 Feb;46(1):47-53. doi: 10.1007/s11262-012-0833-7. Epub 2012 Oct 10.

PMID:
23054435
27.

Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus.

Kumar M, Sudeep AB, Arankalle VA.

Vaccine. 2012 Sep 21;30(43):6142-9. doi: 10.1016/j.vaccine.2012.07.072. Epub 2012 Aug 8.

PMID:
22884660
28.
29.

Cytokine profiles, CTL response and T cell frequencies in the peripheral blood of acute patients and individuals recovered from hepatitis E infection.

Tripathy AS, Das R, Rathod SB, Arankalle VA.

PLoS One. 2012;7(2):e31822. doi: 10.1371/journal.pone.0031822. Epub 2012 Feb 22.

30.

Whole genomes of Chandipura virus isolates and comparative analysis with other rhabdoviruses.

Cherian SS, Gunjikar RS, Banerjee A, Kumar S, Arankalle VA.

PLoS One. 2012;7(1):e30315. doi: 10.1371/journal.pone.0030315. Epub 2012 Jan 17.

31.

Expression profile of immune response genes during acute myopathy induced by chikungunya virus in a mouse model.

Patil DR, Hundekar SL, Arankalle VA.

Microbes Infect. 2012 May;14(5):457-69. doi: 10.1016/j.micinf.2011.12.008. Epub 2011 Dec 30.

PMID:
22230246
32.

Survival of hepatitis A and E viruses in soil samples.

Parashar D, Khalkar P, Arankalle VA.

Clin Microbiol Infect. 2011 Nov;17(11):E1-4. doi: 10.1111/j.1469-0691.2011.03652.x. Epub 2011 Sep 21.

33.

Epidemic of hepatitis B with high mortality in India: association of fulminant disease with lack of CCL4 and natural killer T cells.

Tripathy AS, Das R, Chadha MS, Arankalle VA.

J Viral Hepat. 2011 Oct;18(10):e415-22. doi: 10.1111/j.1365-2893.2011.01457.x. Epub 2011 May 18.

PMID:
21914058
35.

Peripheral T regulatory cells and cytokines in hepatitis E infection.

Tripathy AS, Das R, Rathod SB, Gurav YK, Arankalle VA.

Eur J Clin Microbiol Infect Dis. 2012 Feb;31(2):179-84. doi: 10.1007/s10096-011-1291-1. Epub 2011 May 20.

PMID:
21598072
36.

Development of an inactivated candidate vaccine against Chandipura virus (Rhabdoviridae: Vesiculovirus).

Jadi RS, Sudeep AB, Barde PV, Arankalle VA, Mishra AC.

Vaccine. 2011 Jun 20;29(28):4613-7. doi: 10.1016/j.vaccine.2011.04.063. Epub 2011 May 5.

PMID:
21549791
37.

Genomic characterization of Nipah virus, West Bengal, India.

Arankalle VA, Bandyopadhyay BT, Ramdasi AY, Jadi R, Patil DR, Rahman M, Majumdar M, Banerjee PS, Hati AK, Goswami RP, Neogi DK, Mishra AC.

Emerg Infect Dis. 2011 May;17(5):907-9. doi: 10.3201/eid1705.100968.

38.

Investigation of a Chikungunya-like illness in Tirunelveli district, Tamil Nadu, India 2009-2010.

Sudeep AB, Hundekar SL, Jacob PG, Balasubramanian R, Arankalle VA, Mishra AC.

Trop Med Int Health. 2011 May;16(5):585-8. doi: 10.1111/j.1365-3156.2011.02743.x. Epub 2011 Mar 3.

39.

An outbreak of hepatitis B with high mortality in India: association with precore, basal core promoter mutants and improperly sterilized syringes.

Arankalle VA, Gandhi S, Lole KS, Chadha MS, Gupte GM, Lokhande MU.

J Viral Hepat. 2011 Apr;18(4):e20-8. doi: 10.1111/j.1365-2893.2010.01391.x. Epub 2010 Nov 26.

PMID:
21108697
40.

Chandipura virus encephalitis outbreak among children in Nagpur division, Maharashtra, 2007.

Gurav YK, Tandale BV, Jadi RS, Gunjikar RS, Tikute SS, Jamgaonkar AV, Khadse RK, Jalgaonkar SV, Arankalle VA, Mishra AC.

Indian J Med Res. 2010 Oct;132:395-9.

41.

Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients.

Arankalle VA, Lole KS, Arya RP, Tripathy AS, Ramdasi AY, Chadha MS, Sangle SA, Kadam DB.

PLoS One. 2010 Oct 1;5(10). pii: e13099. doi: 10.1371/journal.pone.0013099.

42.

Chandipura virus growth kinetics in vertebrate cell lines, insect cell lines & embryonated eggs.

Jadi RS, Sudeep AB, Kumar S, Arankalle VA, Mishra AC.

Indian J Med Res. 2010 Aug;132:155-9.

43.

Complete genome sequences of hepatitis C virus subtype 3i and 3a subtype isolates from India.

Gupte GM, Ramdasi AY, Kulkarni AS, Arankalle VA.

Indian J Gastroenterol. 2010 Jun;29(3):101-5. doi: 10.1007/s12664-010-0030-3. Epub 2010 Jul 25.

PMID:
20658329
44.

Utility of pandemic H1N1 2009 influenza virus recombinant hemagglutinin protein-based enzyme-linked immunosorbent assay for serosurveillance.

Arankalle VA, Virkar RG, Tandale BV, Ingle NB.

Clin Vaccine Immunol. 2010 Sep;17(9):1481-3. doi: 10.1128/CVI.00223-10. Epub 2010 Jul 14.

45.

Association of HLA alleles with hepatitis C infection in Maharashtra, western India.

Tripathy AS, Shankarkumar U, Chadha MS, Ghosh K, Arankalle VA.

Indian J Med Res. 2009 Nov;130(5):550-5.

PMID:
20090103
46.

Intracranial administration of P gene siRNA protects mice from lethal Chandipura virus encephalitis.

Kumar S, Arankalle VA.

PLoS One. 2010 Jan 7;5(1):e8615. doi: 10.1371/journal.pone.0008615.

47.

A novel HBV recombinant (genotype I) similar to Vietnam/Laos in a primitive tribe in eastern India.

Arankalle VA, Gandhe SS, Borkakoty BJ, Walimbe AM, Biswas D, Mahanta J.

J Viral Hepat. 2010 Jul;17(7):501-10. doi: 10.1111/j.1365-2893.2009.01206.x. Epub 2010 Jan 5.

PMID:
20059669
48.

Evaluation of the immunogenicity of a recombinant glycoprotein-based Chandipura vaccine in combination with commercially available DPT vaccine.

Venkateswarlu CH, Arankalle VA.

Vaccine. 2010 Feb 10;28(6):1463-7. doi: 10.1016/j.vaccine.2009.11.072. Epub 2009 Dec 14.

PMID:
20005854
49.

Hepatitis E virus-based evaluation of a virion concentration method and detection of enteric viruses in environmental samples by multiplex nested RT-PCR.

Verma V, Arankalle VA.

J Appl Microbiol. 2010 May;108(5):1630-41. doi: 10.1111/j.1365-2672.2009.04581.x. Epub 2009 Oct 10.

50.

Investigation of a hepatitis A outbreak from Shimla Himachal Pradesh.

Chobe LP, Arankalle VA.

Indian J Med Res. 2009 Aug;130(2):179-84.

PMID:
19797816

Supplemental Content

Loading ...
Support Center